Monitor for any subsequent Schedule 13D amendments or open-market transactions by BVF entities, which would signal a change in investment thesis. The pre-funded warrants at $0.0001 and Series 1/2 warrants at $13.42/$20.13 provide a clear view of BVF's cost basis and potential dilution overhang.
Price Chart
Executive Summary
BVF entities (Biotechnology Value Fund, BVF Partners, and affiliates) filed a Form 3 initial statement of beneficial ownership for Foghorn Therapeutics Inc. (FHTX), disclosing aggregate holdings of 8,346,768 shares of common stock, 5,840,979 pre-funded warrants (exercise price $0.0001), 1,835,659 Series 1 warrants (expire June 30, 2027, exercise price $13.42), and 1,835,659 Series 2 warrants (expire December 31, 2030, exercise price $20.13). The group collectively owns more than 10% of FHTX outstanding common stock. This is a routine initial ownership filing with no trading activity or change in position, no material stock price impact expected.
Key Facts
- BVF entities filed Form 3 initial statement of beneficial ownership for Foghorn Therapeutics Inc. (FHTX).
- Aggregate common stock holdings: 8,346,768 shares (directly owned by BVF, BVF2, and Trading Fund OS).
- Pre-funded warrants: 5,840,979 shares, exercise price $0.0001, no expiration, subject to 9.99% beneficial ownership limitation.
- Series 1 warrants: 1,835,659 shares, exercise price $13.42, expire June 30, 2027, subject to 9.99% limitation.
- Series 2 warrants: 1,835,659 shares, exercise price $20.13, expire December 31, 2030, subject to 9.99% limitation.
- Group collectively beneficially owns more than 10% of FHTX outstanding common stock.
- Filing date: October 5, 2026; period of report: October 1, 2026.
Financial Impact
No financial impact, initial ownership disclosure only, no transaction or change in position.
Risk Factors
- Potential dilution from exercise of pre-funded and Series 1/2 warrants (aggregate 9,512,297 additional shares).
- BVF group's >10% ownership could lead to activist pressure or strategic influence.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0000921895-26-002730 |
| Document: 0000921895-26-002730-index.html | 0000921895-26-002730 |
| Document: 0000921895-26-002730.txt | 0000921895-26-002730 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 5, 2026 24d ago | 3 | $1.97 | awaiting T+20 | awaiting T+20 | $2.09 (+6.09%) |
Oct 5, 2026 24d ago | SC 13G/A | $1.97 | awaiting T+20 | awaiting T+20 | $2.09 (+6.09%) |
Oct 1, 2026 28d ago | 8-K | $2.92 $2.09 | ▲ +28.42% | ▲ +29.13% | $2.09 (+28.42%) |
Aug 6, 2026 12w ago | 8-K | $5.57 $4.87 | ▼ −12.57% | ▼ −13.17% | $2.09 (−62.48%) |
May 7, 2026 25w ago | 8-K | $4.20 $3.64 | ▼ −13.33% | ▼ −16.47% | $2.09 (−50.24%) |
Apr 21, 2026 27w ago | Press Release | $5.39 $3.60 | ▼ −33.21% | ▼ −36.38% | $2.09 (−61.22%) |
Apr 21, 2026 27w ago | 8-K | $5.39 $3.60 | ▼ −33.21% | ▼ −36.38% | $2.09 (−61.22%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers